Heather Shaw to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Heather Shaw has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.017
-
Reid A, Vidal L, Shaw H, de Bono J. Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu). Eur J Cancer. 2007 Feb; 43(3):481-9.
Score: 0.017